Celltrion Healthcare Co.
Scope
Date
~
-
Markets
Celltrion to allot cash, stock dividend at once
South Korea’s biosimilar maker Celltrion Inc. on Friday announced a plan to allot cash and stock dividends simultaneously. The company wi...
Dec 13, 2024 (Gmt+09:00)
-
Bio & Pharma
Celltrion gets approval of Omlyclo in Canada
South Korea’s Celltrion Inc., received new drug submission (NDS) approval from Health Canada for Omlyclo, the biosimilar of allergic asthma an...
Dec 09, 2024 (Gmt+09:00)
-
Aerospace & Defense
Boryung invests $10 million in Intuitive Machines
South Korea's Boryung Corp. said on Friday it bought $10.0 million in shares of US-based lunar lander company Intuitive Machines to expand its space...
Dec 06, 2024 (Gmt+09:00)
-
Shareholder value
Celltrion to retire $400 mn treasury stock in January
South Korea’s biosimilar maker Celltrion Inc. on Wednesday announced a plan to retire about a quarter of its treasury stock worth 563 billion ...
Dec 04, 2024 (Gmt+09:00)
-
Artificial intelligence
Bespin Global, Upstage to co-work on AI platform
South Korea's cloud solution provider Bespin Global said on Monday it signed with Upstage, the domestic artificial intelligence (AI) startup, to bui...
Dec 02, 2024 (Gmt+09:00)
-
Bio & Pharma
Celltrion to break ground on CDMO plant in 2025: Chairman Seo
South Korea’s leading biosimilar developer Celltrion Inc. will break ground on its first contract development and manufacturing organization (...
Nov 28, 2024 (Gmt+09:00)
-
Executive reshuffles
Samsung reshuffles top brass; Co-CEO to control memory business
Samsung Electronics Co., the world’s No. 1 memory chipmaker, reshuffled its leadership on Wednesday in a sweeping move as it faces an uph...
Nov 27, 2024 (Gmt+09:00)
-
Batteries
Korea Zinc, Hanwha to co-work on Austrailian BESS project
Korea Zinc Inc., the world’s top lead and zinc smelter, said on Tuesday its Australian subsidiary Ark Energy selected Hanwha Corp. as the pref...
Nov 26, 2024 (Gmt+09:00)
-
Bio & Pharma
Celltrion’s Remsima on course to become Korea’s 1st blockbuster drug
Celltrion Inc.'s Remsima, the world’s first biosimilar monoclonal antibody, is on track to exceed 1 trillion won ($713 million) in sales this ...
Nov 25, 2024 (Gmt+09:00)
-
Bio & Pharma
Celltrion to acquire additional $72 mn in treasury shares
South Korea's Celltrion Inc. announced on Thursday that it decided to repurchase additional treasury shares worth 100 billion won ($71.6 million).Fr...
Nov 21, 2024 (Gmt+09:00)
-
Bio & Pharma
Celltrion acquires Swiss pharmaceutical distributor iQone
South Korea's Celltrion Inc. said on Friday that it completed its acquisition of iQone Healthcare Switzerland, a Swiss pharmaceutical distributor, t...
Nov 15, 2024 (Gmt+09:00)
-
Energy
KEPCO, LS Electric to co-work on predictive diagnostics solutions
Korea Electric Power Corp. (KEPCO), the South Korean state-run utility company, said on Thursday it signed a memorandum of understanding (MOU) with ...
Nov 07, 2024 (Gmt+09:00)
-
Korean stock market
MSCI Korea Index adds Hyundai Rotem
MSCI announced on Wednesday that South Korea's Hyundai Rotem Co. will be added to the Morgan Stanley Capital International (MSCI) Korea Index. ...
Nov 07, 2024 (Gmt+09:00)
-
Bio & Pharma
Celltrion releases Steqeyma in Europe
South Korea's Celltrion Inc. said on Monday it released Steqeyma (ustekinumab) in Europe, the biosimilar of autoimmune disease treatment Stelara.T...
Nov 05, 2024 (Gmt+09:00)
-
Energy
HD Hyundai, Amogy, SK to co-work on ammonia-hydrogen power
South Korea's HD Hyundai Infracore Co. said on Monday it partnered with Amogy Inc., a US-based ammonia-powered systems developer, and SK Innova...
Nov 04, 2024 (Gmt+09:00)
-
Korean games
DevSisters, VNG Games sign Cookie Run Asia publishing deal
South Korean game developer DevSisters Corp. said on Friday that it signed a publishing agreement with Vietnamese game company VNG Games for "Cookie...
Nov 01, 2024 (Gmt+09:00)
-
Bio & Pharma
Celltrion's Zymfentra gets 90% distribution channel in US
South Korean biosimilar maker Celltrion Inc. said on Monday its subcutaneous injection formulation for autoimmune diseases, Zymfentra (infliximab), ...
Oct 30, 2024 (Gmt+09:00)
-
Future mobility
Kakao Mobility, Samsung C&T to co-work on robot, parking solutions
Kakao Mobility Corp., South Korea’s largest taxi-hailing app operator, announced on Friday that it signed a business agreement with Samsung C&...
Oct 18, 2024 (Gmt+09:00)
-
Bio & Pharma
Celltrion to establish CDMO subsidiary
Celltrion Inc., South Korea’s largest biosimilar maker, said on Friday it plans to establish a contract development and manufacturing organiza...
Oct 18, 2024 (Gmt+09:00)
-
Tech, Media & Telecom
LG Elec to advance in-cabin sensing solution
LG Electronics Inc. said on Monday it's advancing its in-cabin sensing solution which detects and analyzes the interior of vehicles to prevent acc...
Oct 14, 2024 (Gmt+09:00)
-
Bio & Pharma
Celltrion's anti cancer drugs hold 90% market share in C.America
South Korea’s Celltrion Inc. said on Friday that its cancer treatments have captured a 90% market share in several Central American countries....
Oct 11, 2024 (Gmt+09:00)
-
Electronics
LG NOVA hosts Innovation Festival in US
LG Electronics Inc. 's North American Innovation Center (LG NOVA) said on Monday that it held an Innovation Festival last Wednesday and Thursday at ...
Sep 30, 2024 (Gmt+09:00)
-
Bio & Pharma
Celltrion establishes subsidiary in Vietnam
Celltrion Inc., South Korea’s largest biosimilar maker, said on Monday that it completed the establishment of a local subsidiary in Vietnam....
Sep 30, 2024 (Gmt+09:00)
-
Robotics
CJ Logistics, Aidin Robotics to co-develop logistics robots
South Korea’s CJ Logistics and Aidin Robotics recently signed a memorandum of understanding to co-develop and commercialize logistics robots.U...
Sep 26, 2024 (Gmt+09:00)
-
Companies
Samsung develops health software development kit
Samsung Electronics Co. on Thursday introduced the Samsung Health Software Development Kit (SDK) Suite, aimed at helping developers and researchers ...
Sep 26, 2024 (Gmt+09:00)
-
Batteries
Lotte Energy, Isu Petasys to co-work on HVLP copper foil supply
South Korea's Lotte Energy Materials Corp. said on Monday that it signed a memorandum of understanding (MOU) last Friday with Isu Petasys regardin...
Sep 23, 2024 (Gmt+09:00)
-
Bio & Pharma
Celltrion to supply breast, stomach cancer treatment to Brazil
Celltrion Inc., South Korea’s largest biosimilar maker, announced on Friday that its breast and stomach cancer treatment "Herzuma" (active ing...
Sep 13, 2024 (Gmt+09:00)
-
Food & Beverage
Lotte Wellfood, Topper Guild to co-work for Pepero Day promotion
South Korea’s Lotte Wellfood Co. said on Wednesday it partnered with the US YouTuber Topper Guild to promote Pepero Day.Pepero Day, cele...
Sep 12, 2024 (Gmt+09:00)
-
Bio & Pharma
Celltrion earmarks billions of dollars to build CDMO plant: chairman
Celltrion Inc., South Korea’s largest biosimilar maker, will spend several billion dollars to build a factory to crack the contract developmen...
Sep 11, 2024 (Gmt+09:00)
-
Bio & Pharma
Celltrion chairman announces venture into CDMO market
South Korea’s biosimilar maker Celltrion Inc. will venture into the contract development and manufacturing organization (CDMO) market, the com...
Sep 09, 2024 (Gmt+09:00)
Latest News
- 1 BMW Surpasses Mercedes in Sales – Imported Car Market 'Shake-Up'
- 2 Seoul appeal: Korean art captivates Indonesia’s affluent connoisseurs
- 3 CJ CheilJedang scraps $3.5 bn green bio sale, shifts gears to expansion
- 4 Trump Jr. meets Korean business chiefs in back-to-back sessions
- 5 Samsung in talks to supply customized HBM4 to Nvidia, Broadcom, Google